Abstract
The prevalence of methicillin-resistant and multiply antibiotic-resistant staphylococci causing infections in hospitalized patients was studied over a two-year period. Among 122 clinically significant staphylococci, the prevalence of methicillin resistance was 66 %, with a higher prevalence ofStaphyloccus haemolyticus (85 %) andStaphylococcus epidermidis (83 %) observed than ofStaphylococcus aureus (49 %). Multiple antibiotic resistance was observed more frequently among coagulase-negative staphylococci (52 to 70 %) than amongStaphylococcus aureus (17 %). All strains of methicillin-resistantStaphylococcus aureus were susceptible to glycopeptide antibiotics and to trimethoprim-sulfamethoxazole, whereas approximately 50 % of coagulase-negative staphylococci exhibited either moderate susceptibility or resistance to teicoplanin. For these latter strains, vancomycin remains the agent of choice, whereas teicoplanin cannot be recommended unless its efficacy is established by MIC determination.
Similar content being viewed by others
References
Mulligan ML, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffman CA, Yu VL Methicillin-resistantStaphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. American Journal of Medicine 1993, 94: 313–328.
Keane CT, Cafferkey MT Re-emergence of methicillin resistantStaphylococcus aureus causing infection. Journal of Infection 1984, 9: 6–16.
Brumfitt W, Hamilton-Miller J Methicillin-resistantStaphylococcus aureus. New England Journal of Medicine 1989, 320: 1188–1195.
Davies AJ, Stone JW Current problems of chemotherapy of infections with coagulase-negative staphylococci. European Journal of Clinical Microbiology 1986, 19: 277–281.
Arioli V, Pallanza R Teicoplanin-resistant coagulase-negative staphylococci. Lancet 1981, i: 39.
Schwalbe RS, Stapleton JT, Gilligan PH Emergence of vancomycin resistance in coagulase-negative staphylococci. New England Journal of Medicine 1987, 316: 927–931.
National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A4. NCCLS, Villanova, PA, 1990.
National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. NCCLS, Villanova, PA, 1990.
National Committee for Clinical Laboratory Standards Informational supplement M100-S3. NCCLS, Villanova, PA, 1991.
Bannerman TL, Wadiak DL, Kloos WE Susceptibility ofStaphylococcus species and subspecies to teicoplanin. Antimicrobial Agents and Chemotherapy 1991, 35: 1919–1922.
Low DE, McGeer A, Poon R Activities of daptomycin and teicoplanin againstStaphylococcus haemolyticus andStaphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Antimicrobial Agents and Chemotherapy 1989, 33: 585–588.
Chomarat M, Espinouse D, Flandrois JP Coagulasenegative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity. Journal of Antimicrobial Chemotherapy 1991, 27: 475–480.
Kaatz GW, Seo SM, Dorman JN, Lerner SA Emergence of teicoplanin resistance during therapy ofStaphylococcus aureus endocarditis. Journal of Infectious Diseases 1990, 162: 103–108.
Biavasco F, Giovanetti E, Montanari MP, Lupidi R, Varaldo PE Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. Journal of Antimicrobial Chemotherapy 1991, 27: 71–79.
Shalit I, Berger SA, Gorea A, Frimerman H Widespread quinolone resistance among methicillin-resistantStaphylococcus aureus isolates in a general hospital. Antimicrobial Agents and Chemotherapy 1989, 33: 593–594.
Raviglione MC, Boyle JF, Mariuz P, Pablos-Mendez A, Cortes H, Merlo A Ciprofloxacin-resistant methicillin-resistantStaphylococcus aureus in an acute-care hospital. Antimicrobial Agents and Chemotherapy 1990, 34: 2050–2054.
Froggatt JW, Johnston JL, Galetto DW, Archer GL Antimicrobial resistance in nosocomial isolates ofStaphylococcus haemolyticus. Antimicrobial Agents and Chemotherapy 1989, 33: 460–466.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tripodi, M.F., Attanasio, V., Adinolfi, L.E. et al. Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 13, 148–152 (1994). https://doi.org/10.1007/BF01982189
Issue Date:
DOI: https://doi.org/10.1007/BF01982189